Keurig Dr Pepper to Buy Peet’s Coffee Owner for $18 Billion in Revamp

Keurig Dr Pepper to Buy Peet’s Coffee Owner for $18 Billion in Revamp

Watch Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Alexis Christoforous

-Kenneth Shea, Bloomberg Intelligence Senior Consumer Products Analyst, discusses Keurig Dr Pepper agreeing to buy JDE Peet’s NV for €15.7 billion to bolster its struggling coffee business. The company plans to separate its coffee and soft drinks units into two independent, US-listed companies next year once the deal is completed, according to a statement.

-Poonam Goyal, Senior U.S. E-Commerce and Retail Analyst at Bloomberg Intelligence, discusses the Pinault family reaching out to potential buyers of Puma SE after the company lost about half of its market value in the past year, according to people familiar with the matter.

-Anurag Rana, Bloomberg Intelligence Technology Analyst, discusses Apple kicking off a bold three year plan for its’ iPhone redesign push.

-Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, discusses a potential acquisition of Tegna by Nextar Media Group for $6.2 billion. The merger awaits approval by the FCC and will require navigating antitrust regulations.

See omnystudio.com/listener for privacy information.

Jaksot(3290)

Bloomberg's Goyal, Clavis's Chaudhury: Amazon Prime Day (Audio)

Bloomberg's Goyal, Clavis's Chaudhury: Amazon Prime Day (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Poonam Goyal, Senior Retail Analyst for Bloomberg Intelligence, and Supriya Chaudhury, CMO for Clavis Insight, on the e-commerce performance of Amazon Prime Day.See omnystudio.com/listener for privacy information.

12 Heinä 20168min

Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)

Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Bloomberg stocks editor David Wilson on today's market winners, losers, and Stock of the Day: Belmond (BEL).See omnystudio.com/listener for privacy information.

12 Heinä 201612min

RBC's Golub Favors US Equities In Low Vol Environment (Audio)

RBC's Golub Favors US Equities In Low Vol Environment (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonathan Golub, Chief US Market Strategist for RBC Capital Markets, on the markets, earnings, and why the call for lower returns on equity is too early.See omnystudio.com/listener for privacy information.

12 Heinä 201611min

Conference Board's Maselli on European Labor Markets (Audio)

Conference Board's Maselli on European Labor Markets (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Ilaria Maselli, Senior Economist, Europe, at the Conference Board, on the labor markets and future of employment of Europe.See omnystudio.com/listener for privacy information.

12 Heinä 201611min

Bloomberg's Larson: Why Tech Companies Get Sued in China(Audio)

Bloomberg's Larson: Why Tech Companies Get Sued in China(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Matt Larson, Litigation Analyst for Bloomberg Intelligence, on why tech companies are getting sued in China.See omnystudio.com/listener for privacy information.

12 Heinä 20168min

John Sculley Sees $10 Billion in Revenues for RxAdvance (Audio)

John Sculley Sees $10 Billion in Revenues for RxAdvance (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Former Apple and Pepsi CEO John Sculley on his current entrepreneurial endeavors in healthcare, and the strategies outlined in his new book "Moonshot!: Game-Changing Strategies to Build Billion-Dollar Businesses."See omnystudio.com/listener for privacy information.

12 Heinä 201611min

Pemberton's Durcikova: Investing in Toronto Real Estate (Audio)

Pemberton's Durcikova: Investing in Toronto Real Estate (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Mariana Durcikova, Broker at Pemberton Group, on the benefits to investing in Toronto real estate, compared to NYC.See omnystudio.com/listener for privacy information.

12 Heinä 201611min

Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)

Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.See omnystudio.com/listener for privacy information.

12 Heinä 20168min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
rss-rahapodi
mimmit-sijoittaa
inderespodi
taloudellinen-mielenrauha
ostan-asuntoja-podcast
rss-bisnesta-bebeja
pomojen-suusta
rss-rahamania
lakicast
rss-sisalto-kuntoon
rss-seuraava-potilas
rss-paasipodi
herrasmieshakkerit
juristipodi
jahtaa-unelmiasi
rss-ammattipodcast
rss-salonkipodi
rss-karon-grilli